NCT04184193View on ClinicalTrials.gov

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

December 23, 2019

Study Completion Date

December 23, 2019

Conditions
LymphangioleiomyomatosisLAMPulmonary Rehabilitation
Interventions
OTHER

Pulmonary Rehabilitation

Patients will perform a comprehensive, inpatient pulmonary rehabilitation program for 4 weeks duration

Trial Locations (1)

Unknown

Schoen Klinik Berchtesgadener Land, Schönau am Königssee

All Listed Sponsors
lead

Schön Klinik Berchtesgadener Land

OTHER

NCT04184193 - Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM) | Biotech Hunter | Biotech Hunter